4 research outputs found
Stroke in young and middle age
Autori su analizrali prevalenciju moždanog udara u grupi hospitalno lijeÄenih bolesnika (482 bolesnika), te u grupi ambulantno lijeÄenih bolesnika (104). Prema rezultatima istraživanja, u mlaÄoj životnoj dobi do 20 godina moždani udar se iznimno javlja u 0,8% sluÄajeva. Isto tako, u mladoj životnoj dobi, do 40 godina, takoÄer se javlja u relativno malom postotku. Nagli skok osjeÄa se iznad 50 godina, a najzastupljeniji je izmeÄu 61ā70. godine. BuduÄi da se moždani udar u relativno visokom postotku javlja u produktivnoj životnoj dobi (20 60 godina), u staconarno lijeÄenih bolesnika sa 39,2%, a u ambulantnih 40,4%, to ova dob kao riziÄna zahtijeva prevenciju uobiÄajenih faktora rizika: praÄenje lipidograma, hipertenzije, kardijalnih bolesti, diabetes mellitusa, a posebno znaÄenje prema miÅ”ljenju autora mogu imati psihiÄki stresogeni faktori. Autori su analizirali mortalitet u odnosu na životnu dob, te se pokazalo da je najveÄi u starijoj životnoj dobi, Å”to se i oÄekivalo. MeÄutim, u relativno visokom postotku od 31,0% javlja se u mladoj i srednjoj životnoj dobi. Ukupna smrtnost je daleko veÄa u grupi stacionarno lijeÄenih pacijenata, gdje iznosi 38,8%, kod ambulantno lijeÄenih 0,96%, Å”to je razumljivo buduÄi da se nerijetko na stacionarno lijeÄenje primaju bolesnici i u moribundnom stanju. Kako moždani dar ostavlja invaliditet, to je posebno znaÄajna incidencija bolesti u produktivnoj dobi, imajuÄi u vidu socijalno ekonomsko znaÄenje posljedica bolesti. Prevencija u ovoj životnoj dobi, koja se može smatrati riziÄnom, zahtijeva neophodnost provoÄenja sistemskih mjera prevencije u zdravoj populaciji.The authors analysed the prevalence of the stroke in the group of 482 in-patients and in the group of 104 out-patients. According to the results obtained by this study the stroke appeared to be very rare (0.8%) in the age group below 20 as well as in the group below 40 years of age. Sudden increase is observed in the group up to 50 and the highest frequency is observed between 61ā70 years. Since the stroke appears most frequently in a product ive age of life (20ā60 years) ā 39. 2% for in-patients and 40.4% for out-patients this age group sholuld beregarded as risky and it is necessary to take preventive follow-up actions (lipidogram, hypertension, cardial diseases, diabetes mellitus) and a special attention should be paid to the psychic stress situation. The authors analysed the mortality in relation to the age. It is higher in old age as it has been expected but it is also high in young and middle age (31%). Mortality was higher in the group of in-patinents (38. 8%) and lower in the group of out patients (0.96%) which is quite understandable since moribund patients with stroke are hospitalised quite offen. If we keep in mind that stroke can result in invalidity, the incidence in a productive age and social economic consequences of disease are of importance and therefore we should impose comprenhensive prevention in the healthy population
Clinical presentation and diagnostic methods of Takayasu arteritis ā case study
Takayasuov arteritis vrlo je rijedak oblik vaskulitisa karakteriziran nejasnim simptomima u ranim fazama bolesti, koji nerijetko ostanu nelijeÄeni kroz dulje vrijeme. U mnogim se sluÄajevima dijagnoza Takayasuovoga arteritisa postavlja u drugoj fazi bolesti kada su razvijene komplikacije kao posljedica stenozirajuÄih promjena na krvnim žilama. Kolor dopler je metoda koju treba izabrati za evaluaciju i praÄenje promjena na stijenkama krvnih žila u svim fazama te bolesti.Takayasu arteritis is a rare form of vasculitis characterized in early phases of the disease by unclear symptoms which may not be recognized for a long period of time. In the majority of Takayasu arteritis cases the diagnosis is first established in the second phase of the disease when the majority of possible complications occur as a consequence of arterial stenosis. Color doppler flow imaging is the diagnostic method of choice for evaluation and follow up of the artery wall thickening progression in all phases of the disease